Prognosis of Resected Ampullary Adenocarcinoma by Preoperative Serum CA19-9 Levels and Platelet-Lymphocyte Ratio View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2008-06-10

AUTHORS

Richard A. Smith, Paula Ghaneh, Robert Sutton, Michael Raraty, Fiona Campbell, John P. Neoptolemos

ABSTRACT

BackgroundThe objective of this study was to evaluate whether preoperative CA19-9 levels and the platelet–lymphocyte ratio (PLR) might reflect prognostic indices for resected ampullary adenocarcinoma.Materials and MethodsData were collected prospectively over a 10-year period for consecutive patients undergoing pancreatoduodenectomy for malignancy.ResultsBoth preoperative PLR and CA19-9 results were available in 52 cases of resected ampullary adenocarcinoma. Preoperative CA19-9 levels of ≤150 kU/l (or ≤300 kU/l in the presence of bilirubin levels >35 µmol/l) and a PLR of ≤160 were found to represent the optimal cut-off values to risk stratify patients. If both levels were elevated (n = 8), patients had a median overall survival of 10.1 months. If either CA19-9 or PLR were elevated individually (n = 23), patients had a median survival of 25.2 months. For cases where both levels were less than the cut-off values (n = 21), the median overall survival time was not reached but was greater than 60 months (log rank, p < 0.001). This preoperative risk stratification was found to remain a significant independent predictor of survival on multivariate analysis (Cox, p = 0.001) alongside resection margin status (p = 0.002) and tumor size (p = 0.051).ConclusionsPreoperative CA19-9 and PLR both merit further evaluation as prognostic indices in resected ampullary adenocarcinoma. More... »

PAGES

1422-1428

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11605-008-0554-3

DOI

http://dx.doi.org/10.1007/s11605-008-0554-3

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1022255030

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/18543046


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adenocarcinoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomarkers, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Platelets", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "CA-19-9 Antigen", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphocyte Count", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphocytes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pancreatic Ducts", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pancreatic Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pancreaticoduodenectomy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Platelet Count", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Division of Surgery and Oncology, School of Cancer Studies, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St., L69 3GA, Liverpool, UK", 
          "id": "http://www.grid.ac/institutes/grid.415970.e", 
          "name": [
            "Division of Surgery and Oncology, School of Cancer Studies, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St., L69 3GA, Liverpool, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Smith", 
        "givenName": "Richard A.", 
        "id": "sg:person.014067200621.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014067200621.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Surgery and Oncology, School of Cancer Studies, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St., L69 3GA, Liverpool, UK", 
          "id": "http://www.grid.ac/institutes/grid.415970.e", 
          "name": [
            "Division of Surgery and Oncology, School of Cancer Studies, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St., L69 3GA, Liverpool, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ghaneh", 
        "givenName": "Paula", 
        "id": "sg:person.07372440237.86", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07372440237.86"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Surgery and Oncology, School of Cancer Studies, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St., L69 3GA, Liverpool, UK", 
          "id": "http://www.grid.ac/institutes/grid.415970.e", 
          "name": [
            "Division of Surgery and Oncology, School of Cancer Studies, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St., L69 3GA, Liverpool, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sutton", 
        "givenName": "Robert", 
        "id": "sg:person.0673243233.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673243233.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Surgery and Oncology, School of Cancer Studies, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St., L69 3GA, Liverpool, UK", 
          "id": "http://www.grid.ac/institutes/grid.415970.e", 
          "name": [
            "Division of Surgery and Oncology, School of Cancer Studies, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St., L69 3GA, Liverpool, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Raraty", 
        "givenName": "Michael", 
        "id": "sg:person.014701673553.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014701673553.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St, L69 3GA, Liverpool, UK", 
          "id": "http://www.grid.ac/institutes/grid.415970.e", 
          "name": [
            "Department of Pathology, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St, L69 3GA, Liverpool, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Campbell", 
        "givenName": "Fiona", 
        "id": "sg:person.0646035141.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0646035141.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Surgery and Oncology, School of Cancer Studies, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St., L69 3GA, Liverpool, UK", 
          "id": "http://www.grid.ac/institutes/grid.415970.e", 
          "name": [
            "Division of Surgery and Oncology, School of Cancer Studies, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St., L69 3GA, Liverpool, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Neoptolemos", 
        "givenName": "John P.", 
        "id": "sg:person.0750565077.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750565077.18"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf02573067", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035777874", 
          "https://doi.org/10.1007/bf02573067"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02305535", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048784717", 
          "https://doi.org/10.1007/bf02305535"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6602305", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043982539", 
          "https://doi.org/10.1038/sj.bjc.6602305"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01542654", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027172486", 
          "https://doi.org/10.1007/bf01542654"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1994.93", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037762550", 
          "https://doi.org/10.1038/bjc.1994.93"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2008-06-10", 
    "datePublishedReg": "2008-06-10", 
    "description": "BackgroundThe objective of this study was to evaluate whether preoperative CA19-9 levels and the platelet\u2013lymphocyte ratio (PLR) might reflect prognostic indices for resected ampullary adenocarcinoma.Materials and MethodsData were collected prospectively over a 10-year period for consecutive patients undergoing pancreatoduodenectomy for malignancy.ResultsBoth preoperative PLR and CA19-9 results were available in 52 cases of resected ampullary adenocarcinoma. Preoperative CA19-9 levels of \u2264150\u00a0kU/l (or \u2264300\u00a0kU/l in the presence of bilirubin levels >35\u00a0\u00b5mol/l) and a PLR of \u2264160 were found to represent the optimal cut-off values to risk stratify patients. If both levels were elevated (n = 8), patients had a median overall survival of 10.1\u00a0months. If either CA19-9 or PLR were elevated individually (n = 23), patients had a median survival of 25.2\u00a0months. For cases where both levels were less than the cut-off values (n = 21), the median overall survival time was not reached but was greater than 60\u00a0months (log rank, p < 0.001). This preoperative risk stratification was found to remain a significant independent predictor of survival on multivariate analysis (Cox, p = 0.001) alongside resection margin status (p = 0.002) and tumor size (p = 0.051).ConclusionsPreoperative CA19-9 and PLR both merit further evaluation as prognostic indices in resected ampullary adenocarcinoma.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s11605-008-0554-3", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1116755", 
        "issn": [
          "1091-255X", 
          "1873-4626"
        ], 
        "name": "Journal of Gastrointestinal Surgery", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "8", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "12"
      }
    ], 
    "keywords": [
      "platelet-lymphocyte ratio", 
      "CA19-9 levels", 
      "preoperative CA19-9 levels", 
      "ampullary adenocarcinoma", 
      "prognostic index", 
      "CA19-9", 
      "preoperative serum CA19-9 level", 
      "preoperative platelet-lymphocyte ratio", 
      "median overall survival time", 
      "serum CA19-9 levels", 
      "median overall survival", 
      "preoperative risk stratification", 
      "resection margin status", 
      "overall survival time", 
      "significant independent predictors", 
      "merit further evaluation", 
      "median survival", 
      "consecutive patients", 
      "overall survival", 
      "margin status", 
      "risk stratification", 
      "independent predictors", 
      "tumor size", 
      "BackgroundThe objective", 
      "survival time", 
      "adenocarcinoma", 
      "patients", 
      "multivariate analysis", 
      "kU/", 
      "further evaluation", 
      "months", 
      "survival", 
      "pancreatoduodenectomy", 
      "levels", 
      "prognosis", 
      "malignancy", 
      "MethodsData", 
      "index", 
      "risk", 
      "predictors", 
      "cases", 
      "status", 
      "stratification", 
      "period", 
      "evaluation", 
      "study", 
      "ratio", 
      "objective", 
      "values", 
      "time", 
      "analysis", 
      "results", 
      "size", 
      "materials"
    ], 
    "name": "Prognosis of Resected Ampullary Adenocarcinoma by Preoperative Serum CA19-9 Levels and Platelet-Lymphocyte Ratio", 
    "pagination": "1422-1428", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1022255030"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11605-008-0554-3"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "18543046"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11605-008-0554-3", 
      "https://app.dimensions.ai/details/publication/pub.1022255030"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T15:53", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_473.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s11605-008-0554-3"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11605-008-0554-3'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11605-008-0554-3'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11605-008-0554-3'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11605-008-0554-3'


 

This table displays all metadata directly associated to this object as RDF triples.

244 TRIPLES      21 PREDICATES      102 URIs      89 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11605-008-0554-3 schema:about N1f6b9eb828f6473091b1c122cd5f30e5
2 N2c77fa43ee3248ab96347173603fa484
3 N4166e6cdb54c452ab62220880fa98230
4 N4771a9b1c4e7404fb3e9e97706a80c00
5 N62513b207d88457c81e8b280b32b4f3d
6 N632445413e9347b8b9066c1ca0f36794
7 N63a54a34cd254e22b8dd45387298c7bc
8 N6b5069683d3841299973f0099fbbec6c
9 N70155b8fd0ea4db28da2f7e18b1f0278
10 N79a968c3096b4592967b2781a5558f23
11 N97f152ac600c491fa8687db5684f5635
12 Naca71defc7d44f82af302588b2ffc963
13 Nba1b50b159c546f087f2edbabcfc1c91
14 Nc71ed6fd47264c16b0657d805746cd23
15 Nca343339d4dc424ba450ada1b49a1e63
16 Nd52d5f455f6747629fa7f634f9c629eb
17 Nda5b6801719c4717b7609da8b0f7a979
18 Ndf156f9adba541c0bcc8bde48f505b4a
19 anzsrc-for:11
20 anzsrc-for:1112
21 schema:author N91675558ae4640abb820846b63f847b9
22 schema:citation sg:pub.10.1007/bf01542654
23 sg:pub.10.1007/bf02305535
24 sg:pub.10.1007/bf02573067
25 sg:pub.10.1038/bjc.1994.93
26 sg:pub.10.1038/sj.bjc.6602305
27 schema:datePublished 2008-06-10
28 schema:datePublishedReg 2008-06-10
29 schema:description BackgroundThe objective of this study was to evaluate whether preoperative CA19-9 levels and the platelet–lymphocyte ratio (PLR) might reflect prognostic indices for resected ampullary adenocarcinoma.Materials and MethodsData were collected prospectively over a 10-year period for consecutive patients undergoing pancreatoduodenectomy for malignancy.ResultsBoth preoperative PLR and CA19-9 results were available in 52 cases of resected ampullary adenocarcinoma. Preoperative CA19-9 levels of ≤150 kU/l (or ≤300 kU/l in the presence of bilirubin levels >35 µmol/l) and a PLR of ≤160 were found to represent the optimal cut-off values to risk stratify patients. If both levels were elevated (n = 8), patients had a median overall survival of 10.1 months. If either CA19-9 or PLR were elevated individually (n = 23), patients had a median survival of 25.2 months. For cases where both levels were less than the cut-off values (n = 21), the median overall survival time was not reached but was greater than 60 months (log rank, p < 0.001). This preoperative risk stratification was found to remain a significant independent predictor of survival on multivariate analysis (Cox, p = 0.001) alongside resection margin status (p = 0.002) and tumor size (p = 0.051).ConclusionsPreoperative CA19-9 and PLR both merit further evaluation as prognostic indices in resected ampullary adenocarcinoma.
30 schema:genre article
31 schema:isAccessibleForFree false
32 schema:isPartOf Nd44de97ef0c04691ac3ba4f197a1b8ea
33 Ndd5208797c7045b68aa99081662a924e
34 sg:journal.1116755
35 schema:keywords BackgroundThe objective
36 CA19-9
37 CA19-9 levels
38 MethodsData
39 adenocarcinoma
40 ampullary adenocarcinoma
41 analysis
42 cases
43 consecutive patients
44 evaluation
45 further evaluation
46 independent predictors
47 index
48 kU/
49 levels
50 malignancy
51 margin status
52 materials
53 median overall survival
54 median overall survival time
55 median survival
56 merit further evaluation
57 months
58 multivariate analysis
59 objective
60 overall survival
61 overall survival time
62 pancreatoduodenectomy
63 patients
64 period
65 platelet-lymphocyte ratio
66 predictors
67 preoperative CA19-9 levels
68 preoperative platelet-lymphocyte ratio
69 preoperative risk stratification
70 preoperative serum CA19-9 level
71 prognosis
72 prognostic index
73 ratio
74 resection margin status
75 results
76 risk
77 risk stratification
78 serum CA19-9 levels
79 significant independent predictors
80 size
81 status
82 stratification
83 study
84 survival
85 survival time
86 time
87 tumor size
88 values
89 schema:name Prognosis of Resected Ampullary Adenocarcinoma by Preoperative Serum CA19-9 Levels and Platelet-Lymphocyte Ratio
90 schema:pagination 1422-1428
91 schema:productId N598d2af299554278afff698501b303e3
92 N64257b37fa1f4c99886aff05a250fba7
93 N68f9e439d8114464913ad30c793eff64
94 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022255030
95 https://doi.org/10.1007/s11605-008-0554-3
96 schema:sdDatePublished 2022-09-02T15:53
97 schema:sdLicense https://scigraph.springernature.com/explorer/license/
98 schema:sdPublisher N552ec81728a44a73bcbd7411f7b7ba9a
99 schema:url https://doi.org/10.1007/s11605-008-0554-3
100 sgo:license sg:explorer/license/
101 sgo:sdDataset articles
102 rdf:type schema:ScholarlyArticle
103 N1f6b9eb828f6473091b1c122cd5f30e5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name CA-19-9 Antigen
105 rdf:type schema:DefinedTerm
106 N273a9b7e3f594989b1614708a7f8b554 rdf:first sg:person.0646035141.16
107 rdf:rest N5fc51b42877a450eab7aad4ed19038c2
108 N28b1f2b2519442fe9a9a06c7f0d63633 rdf:first sg:person.014701673553.45
109 rdf:rest N273a9b7e3f594989b1614708a7f8b554
110 N2c77fa43ee3248ab96347173603fa484 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Female
112 rdf:type schema:DefinedTerm
113 N3fba17d1521d4619882f3ee5d80830dd rdf:first sg:person.07372440237.86
114 rdf:rest Nca20e9898f0e4a83a85e3549fb10719d
115 N4166e6cdb54c452ab62220880fa98230 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Pancreatic Ducts
117 rdf:type schema:DefinedTerm
118 N4771a9b1c4e7404fb3e9e97706a80c00 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Male
120 rdf:type schema:DefinedTerm
121 N552ec81728a44a73bcbd7411f7b7ba9a schema:name Springer Nature - SN SciGraph project
122 rdf:type schema:Organization
123 N598d2af299554278afff698501b303e3 schema:name doi
124 schema:value 10.1007/s11605-008-0554-3
125 rdf:type schema:PropertyValue
126 N5fc51b42877a450eab7aad4ed19038c2 rdf:first sg:person.0750565077.18
127 rdf:rest rdf:nil
128 N62513b207d88457c81e8b280b32b4f3d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Middle Aged
130 rdf:type schema:DefinedTerm
131 N632445413e9347b8b9066c1ca0f36794 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Lymphocyte Count
133 rdf:type schema:DefinedTerm
134 N63a54a34cd254e22b8dd45387298c7bc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Blood Platelets
136 rdf:type schema:DefinedTerm
137 N64257b37fa1f4c99886aff05a250fba7 schema:name dimensions_id
138 schema:value pub.1022255030
139 rdf:type schema:PropertyValue
140 N68f9e439d8114464913ad30c793eff64 schema:name pubmed_id
141 schema:value 18543046
142 rdf:type schema:PropertyValue
143 N6b5069683d3841299973f0099fbbec6c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Biomarkers, Tumor
145 rdf:type schema:DefinedTerm
146 N70155b8fd0ea4db28da2f7e18b1f0278 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Prognosis
148 rdf:type schema:DefinedTerm
149 N79a968c3096b4592967b2781a5558f23 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Pancreaticoduodenectomy
151 rdf:type schema:DefinedTerm
152 N91675558ae4640abb820846b63f847b9 rdf:first sg:person.014067200621.05
153 rdf:rest N3fba17d1521d4619882f3ee5d80830dd
154 N97f152ac600c491fa8687db5684f5635 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Adenocarcinoma
156 rdf:type schema:DefinedTerm
157 Naca71defc7d44f82af302588b2ffc963 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Humans
159 rdf:type schema:DefinedTerm
160 Nba1b50b159c546f087f2edbabcfc1c91 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Follow-Up Studies
162 rdf:type schema:DefinedTerm
163 Nc71ed6fd47264c16b0657d805746cd23 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Aged
165 rdf:type schema:DefinedTerm
166 Nca20e9898f0e4a83a85e3549fb10719d rdf:first sg:person.0673243233.66
167 rdf:rest N28b1f2b2519442fe9a9a06c7f0d63633
168 Nca343339d4dc424ba450ada1b49a1e63 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Platelet Count
170 rdf:type schema:DefinedTerm
171 Nd44de97ef0c04691ac3ba4f197a1b8ea schema:issueNumber 8
172 rdf:type schema:PublicationIssue
173 Nd52d5f455f6747629fa7f634f9c629eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Prospective Studies
175 rdf:type schema:DefinedTerm
176 Nda5b6801719c4717b7609da8b0f7a979 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Lymphocytes
178 rdf:type schema:DefinedTerm
179 Ndd5208797c7045b68aa99081662a924e schema:volumeNumber 12
180 rdf:type schema:PublicationVolume
181 Ndf156f9adba541c0bcc8bde48f505b4a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Pancreatic Neoplasms
183 rdf:type schema:DefinedTerm
184 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
185 schema:name Medical and Health Sciences
186 rdf:type schema:DefinedTerm
187 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
188 schema:name Oncology and Carcinogenesis
189 rdf:type schema:DefinedTerm
190 sg:journal.1116755 schema:issn 1091-255X
191 1873-4626
192 schema:name Journal of Gastrointestinal Surgery
193 schema:publisher Springer Nature
194 rdf:type schema:Periodical
195 sg:person.014067200621.05 schema:affiliation grid-institutes:grid.415970.e
196 schema:familyName Smith
197 schema:givenName Richard A.
198 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014067200621.05
199 rdf:type schema:Person
200 sg:person.014701673553.45 schema:affiliation grid-institutes:grid.415970.e
201 schema:familyName Raraty
202 schema:givenName Michael
203 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014701673553.45
204 rdf:type schema:Person
205 sg:person.0646035141.16 schema:affiliation grid-institutes:grid.415970.e
206 schema:familyName Campbell
207 schema:givenName Fiona
208 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0646035141.16
209 rdf:type schema:Person
210 sg:person.0673243233.66 schema:affiliation grid-institutes:grid.415970.e
211 schema:familyName Sutton
212 schema:givenName Robert
213 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673243233.66
214 rdf:type schema:Person
215 sg:person.07372440237.86 schema:affiliation grid-institutes:grid.415970.e
216 schema:familyName Ghaneh
217 schema:givenName Paula
218 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07372440237.86
219 rdf:type schema:Person
220 sg:person.0750565077.18 schema:affiliation grid-institutes:grid.415970.e
221 schema:familyName Neoptolemos
222 schema:givenName John P.
223 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750565077.18
224 rdf:type schema:Person
225 sg:pub.10.1007/bf01542654 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027172486
226 https://doi.org/10.1007/bf01542654
227 rdf:type schema:CreativeWork
228 sg:pub.10.1007/bf02305535 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048784717
229 https://doi.org/10.1007/bf02305535
230 rdf:type schema:CreativeWork
231 sg:pub.10.1007/bf02573067 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035777874
232 https://doi.org/10.1007/bf02573067
233 rdf:type schema:CreativeWork
234 sg:pub.10.1038/bjc.1994.93 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037762550
235 https://doi.org/10.1038/bjc.1994.93
236 rdf:type schema:CreativeWork
237 sg:pub.10.1038/sj.bjc.6602305 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043982539
238 https://doi.org/10.1038/sj.bjc.6602305
239 rdf:type schema:CreativeWork
240 grid-institutes:grid.415970.e schema:alternateName Department of Pathology, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St, L69 3GA, Liverpool, UK
241 Division of Surgery and Oncology, School of Cancer Studies, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St., L69 3GA, Liverpool, UK
242 schema:name Department of Pathology, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St, L69 3GA, Liverpool, UK
243 Division of Surgery and Oncology, School of Cancer Studies, Royal Liverpool University Hospital, 5th Floor UCD Building, Daulby St., L69 3GA, Liverpool, UK
244 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...